STAAR SURGICAL CO — Director's Dealing 2021

Mar 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-03-09

Reporting Person: Barnes Scott D (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-09	Common Stock	M	4800	$16.15	Acquired	25190	Direct
2021-03-09	Common Stock	M	188	$29.80	Acquired	25378	Direct
2021-03-09	Common Stock	M	2345	$35.98	Acquired	27723	Direct
2021-03-09	Common Stock	D	3300	$88.48	Disposed	24423	Direct
2021-03-09	Common Stock	D	4033	$89.25	Disposed	20390	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-09	Common Stock Options	$16.15	M	4800	Disposed	2028-03-14	Common Stock (4800)	Direct
2021-03-09	Common Stock Options	$29.80	M	188	Disposed	2028-06-13	Common Stock (188)	Direct
2021-03-09	Common Stock Options	$35.98	M	2345	Disposed	2029-03-13	Common Stock (2345)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.04 to $89.00, inclusive.

F2: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2021.

F3: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021.

F4: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.